Pharma People on the Move: Fall 2022 Roundup – PharmaLive
PCI Pharma Services | Contract Pharma
INITIATOR PHARMA: H1 2020 report
Molecules | Free Full-Text | Spotlight on the Life Cycle of Acrylamide-Based Polymers Supporting Reductions in Environmental Footprint: Review and Recent Advances
Perimeter Protection: Top 10 X-ray Images
Sustainable Medicines Packaging Awards Finalists Announced | Healthcare Packaging
Nano Spotlight System Model 9410
Biomedical researchers have a new treatment of erectile dysfunction on the way
Påminnelse om nyttjande av teckningsoptioner av serie TO 1 i Initiator Pharma A/S
Detailed Understanding of Solvent Effects for the Cationic Ring-Opening Polymerization of 2-Ethyl-2-oxazoline | Macromolecules
Publication of memorandum
DLA Piper assists Initiator Pharma A/S with list change from Spotlight Stock Market to Nasdaq First North Growth Market Sweden | DLA Piper
Market Notice 181/21 – Last day of trading in Initiator Pharma AB's BTA
INITIATOR PHARMA: YEAR END REPORT 2019
Initiator Pharma - Phase 2a study with IP2018 update
DLA Piper assists Initiator Pharma A/S with list change from Spotlight Stock Market to Nasdaq First North Growth Market Sweden | DLA Piper
Today, the subscription period begins in Initiator Pharma's rights issue
Initiator Pharma A/S publishes information memorandum in connection with the change of listing to Nasdaq First North Growth Mark
Ahammad Jawad Vp - Senior Pharmacist - AMERICAN ONCOLOGY INSTITUTE - Precision Cancer Care | LinkedIn
Initiator Pharma A/S | Nordic Issuing
Initiator Pharma (INIT) aktie | Videos - Börskollen
